TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 5, 2005, Pages 707-712

  Baucheron, Sylvie ^a   Mouline, Christian ^a   Praud, Karine ^a   Chaslus Dancla, Elisabeth ^a   Cloeckaert, Axel ^a  

^a CEMAGREF   (France)

Author keywords

Bile salts; Detergents; Efflux systems; Infections; Inhibitors

Indexed keywords

2 NAPHTHYLAMINE; ACRB PROTEIN; BILE SALT; DEOXYCHOLATE SODIUM; DETERGENT; GLYCOPROTEIN P; TOLC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; CECUM; CHICKEN; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; FECES ANALYSIS; GENE DELETION; GENE INACTIVATION; GENE INSERTION; GROWTH INHIBITION; IN VITRO STUDY; INOCULATION; LD 50; LIVER PARENCHYMA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SPLEEN; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BILE ACIDS AND SALTS; CARRIER PROTEINS; CHICKENS; DETERGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI PROTEINS; INTESTINES; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; POULTRY DISEASES; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 18844436674     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki091     Document Type: Article

References (29)

1. Tauxe, R. V. (1999). Salmonella Enteritidis and Salmonella Typhimurium DT104: successful subtypes in the modern world. In Emerging Infections (Scheld, W. M., Craig, W. A. & Hughes, J. M., Eds), pp. 37-53. ASM Press, Washington, DC, USA.
2. Boyd, D., Peters, G. A., Cloeckaert, A. et al. (2001). Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. Journal of Bacteriology 183, 5725-32.
3. Threlfall, E. J. (2000). Epidemic Salmonella Typhimurium DT104: a truly international multiresistant clone. Journal of Antimicrobial Chemotherapy 46, 7-10.
4. Molbak, K., Baggesen, D. L., Aarestrup, F. M. et al. (1999). An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. New England Journal of Medicine 341, 1420-5.
5. Guerra, B., Malorny, B., Schroeter, A. et al. (2003). Multiple resistance mechanisms in fluoroquinolone-resistant salmonella isolates from Germany. Antimicrobial Agents and Chemotherapy 47, 2059.
6. Heisig, P., Kratz, B., Halle, E. et al. (1995). Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany. Microbial Drug Resistance 1, 211-8.
7. Baucheron, S., Imberechts, H., Chaslus-Dancla, E. et al. (2002). The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microbial Drug Resistance 8, 281-9.
8. Cloeckaert, A. & Chaslus-Dancla, E. (2001). Mechanisms of quinolone resistance in Salmonella. Veterinary Research 32, 291-300.
9. Hansen, H. & Heisig, P. (2003). Topoisomerase IV mutations in quinolone-resistant Salmonellae selected in vitro. Microbial Drug Resistance 9, 25-32.
10. Baucheron, S., Chaslus-Dancla, E. & Cloeckaert, A. (2004). Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium DT204. Journal of Antimicrobial Chemotherapy 53, 657-9.
11. Giraud, E., Cloeckaert, A., Kerboeuf, D. et al. (2000). Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrobial Agents and Chemotherapy 44, 1223-8.
12. Fralick, J. A. (1996). Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. Journal of Bacteriology 178, 5803-5.
13. Poole, K. (2004). Efflux-mediated multiresistance in Gram-negative bacteria. Clinical Microbiology and Infection 10, 12-26.
14. Murakami, S., Nakashima, R., Yamashita, E. et al. (2002). Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419, 587-93.
15. Koronakis, V., Sharff, A., Koronakis, E. et al. (2000). Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914-9.
16. Zgurskaya, H. I. & Nikaido, H. (1999). Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proceedings of the National Academy of Sciences USA 96, 7190-5.
17. Lacroix, F. J., Cloeckaert, A., Grepinet, O. et al. (1996). Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiology Letters 135, 161-7.
18. Lin, J., Sahin, O., Michel, L. O. et al. (2003). Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infection and Immunity 71, 4250-9.
19. Bina, J. E. & Mekalanos, J. J. (2001). Vibrio cholerae tolC is required for bile resistance and colonization. Infection and Immunity 69, 4681-5.
20. Sulavik, M. C., Houseweart, C., Cramer, C. et al. (2001). Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrobial Agents and Chemotherapy 45, 1126-36.
21. Thanassi, D. G., Cheng, L. W. & Nikaido, H. (1997). Active efflux of bile salts by Escherichia coli. Journal of Bacteriology 179, 2512-8.
22. Stone, B. J. & Miller, V. L. (1995). Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB/c mice. Molecular Microbiology 17, 701-12.
23. Gunn, J. S., (2000). Mechanisms of bacterial resistance and response to bile. Microbes and Infection 2, 907-13.
24. Lomovskaya, O., Warren, M. S., Lee, A. et al. (2001). Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrobial Agents and Chemotherapy 45, 105-16.
25. Mazzariol, A., Tokue, Y., Kanegawa, T. M. et al. (2000). High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrobial Agents and Chemotherapy 44, 3441-3.
26. Baucheron, S., Tyler, S., Boyd, D. et al. (2004). AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrobial Agents and Chemotherapy 48, 3729-35.
27. Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli k-12 using PCR products. Proceedings of the National Academy of Sciences USA 97, 6640-5.
28. Davis, B. D., Dulbecco, R., Eisen, H. N., et al. (1973). Computation of 50% endpoints (LD50 or ID50) by method of Reed and Muench. In Microbiology, pp. 663-4. Harper International edn, Hagerstown, MD, USA.
29. Higgins, M. K., Eswaran, J., Edwards, P. et al. (2004). Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. Journal of Molecular Biology 342, 697-702.